Conformational Plasticity in Broadly Neutralizing HIV-1 Antibodies Triggers Polyreactivity
Julie Prigent(Inserm), Hugo Mouquet(Institut Pasteur), Annaëlle Jarossay(Inserm), Oxana Vratskikh(Inserm), Timothée Bruel(Institut Pasteur), Cyril Planchais(Institut Pasteur), Caroline Eden(Rockefeller University), Valérie Lorin(Inserm), Ayrin Kök(Inserm), Olivier Schwartz(Centre National de la Recherche Scientifique), Thérèse Couderc(Inserm), Jordan D. Dimitrov(Inserm), Michael S. Seaman(Beth Israel Deaconess Medical Center), Oliver Ohlenschläger(Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)), Jérémy Dufloo(Institute for Integrative Systems Biology)
Cited by 66
Related Papers
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease
|PLoS Pathogens|2008|610
Complex-type <i>N</i> -glycan recognition by potent broadly neutralizing HIV antibodies
|Proceedings of the National Academy of Sciences|2012|576